Haupt Pharma, one of Europe's leading contract developers and manufacturers, was successfully inspected by the local authority (Ibaraki prefecture) at the end of October at its site in Toride, Japan without any significant observation being issued.
GVK Biosciences (GVK BIO), Asia’s leading drug discovery research and development organisation, announced today that it has entered into a drug discovery alliance with the Moulder Center for Drug Discovery Research at Temple University.
With the recent launch of the Haptoglobin and Ceruloplasmin assays Randox now have one of the largest ranges of immunoturbidimetric proteins on the market. All reagents are liquid ready to use for added convenience; furthermore, automated applications are available for most chemistry systems eliminating the need for specialised protein analysers.
The MultiTest 50 is manual tablet testing system that offers highest precision, flexibility and exceptional user-friendliness. From basic tablet hardness tests to complete measuring of up to five parameters, including professional reporting, physical testing has never been easier. Next to fast and efficient operation, the MultiTest 50 provides accurate and highly reliable test data, resulting in increased productivity and ease of regulatory compliance.
GVK Biosciences (GVK BIO), Asia’s leading drug discovery research and development organisation, announced today a new partnership with the PROOF Centre of Excellence, focusing on biomarker development for heart, lung and kidney failure.
Vitamin B12 is found in many immunoassay controls. However, it is normally present at high, clinically insignificant levels, unsuitable when assessing assay sensitivity and performance at the clinical decision level. The Randox Acusera range of immunoassay controls provides clinically relevant levels capable of accurately assessing the sensitivity of vitamin B12 assays.
The RX suzuka is the latest addition to the RX series of clinical chemistry analysers from Randox. As the largest of the RX series the RX suzuka is capable of carrying out up to 800 photometric tests per hour or 1200 tests per hour including ISEs, providing laboratories with increased efficiency and productivity.
Exploristics, the innovative analytics group, now offers a suite of state-of-the-art predictive modelling tools for optimising drug supply and patient recruitment in clinical trials.
An article by SHL Group on the topic "Insight into the Manufcturing of an Auto Injectory", by Marketing Director Steven Kaufman was recently featured in InPharm's Manufacturing & Production Guide.
APL has reinforced its management team by recruiting Kia Frenssen as director of special pharmaceuticals and Åsa Falk as director of sourcing and supply chain.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.